Transition-Metal-Based Nanozymes: Synthesis, Mechanisms of Therapeutic Action, and Applications in Cancer Treatment

Qinrui Fu1, Chuang Wei1, Mengzhen Wang1

  • 1Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao 266021, People's Republic of China.

ACS Nano
|May 2, 2024
PubMed

Insights

Transition-metal nanozymes are advanced nanodrugs for cancer treatment. This review details their preparation, catalytic mechanisms, and diverse therapeutic applications, guiding future clinical use.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Nanotechnology
  • Oncology

Background:

  • Cancer remains a leading global cause of death, necessitating novel therapeutic strategies.
  • Transition-metal-based nanozymes represent a promising class of nanodrugs for advanced cancer therapy.
  • Recent advancements focus on developing efficient and targeted nanozyme-based treatments.

Purpose of the Study:

  • To provide a comprehensive review of transition-metal-based nanozymes for cancer treatment.
  • To outline preparation strategies, catalytic mechanisms, and regulatory approaches for nanozymes.
  • To discuss diverse therapeutic applications and future directions in the field.

Main Methods:

  • Review of synthesis methods including hydrothermal, solvothermal, chemical reduction, biomimetic mineralization, and sol-gel.
  • Elucidation of nanozyme catalytic activities: catalase (CAT)-like, peroxidase (POD)-like, oxidase (OXD)-like, and superoxide dismutase (SOD)-like.
  • Analysis of activity regulation strategies: morphology, size, composition, and surface modification.

Main Results:

  • Detailed overview of various preparation techniques for transition-metal nanozymes.
  • Explanation of multiple catalytic mechanisms and strategies for optimizing nanozyme activity.
  • Exploration of applications in radiotherapy, chemodynamic therapy, photodynamic therapy, photothermal therapy, sonodynamic therapy, immunotherapy, and synergistic therapy.

Conclusions:

  • Transition-metal nanozymes offer versatile platforms for cancer therapy with diverse catalytic activities.
  • Optimizing nanozyme properties and understanding their mechanisms are crucial for therapeutic efficacy.
  • Further research and development are needed to overcome challenges and enhance clinical translation of nanozyme-based cancer treatments.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.1K
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
12.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K